Penumbra (PEN) Earnings Date & Reports

Penumbra Inc is a thrombectomy company focused on developing technologies for challenging medical conditions such as ischemic stroke, venous thromboembolism (including pulmonary embolism), and acute limb ischemia... Show more

Industry: #Medical Specialties

Get AI intraday signals

A.I. Advisor

published Earnings

PEN is expected to report earnings to rise 42.68% to $1.17 per share on August 04

Q2'26

Est.

$1.17

Q1'26

Missed

by $0.25

Q4'25

Beat

by $0.08

Q3'25

Beat

by $0.04

Q2'25

Beat

by $0.03

The last earnings report on May 06 showed earnings per share of 81 cents, missing the estimate of $1.07. With 59.37K shares outstanding, the current market capitalization sits at 12.52B.

View a ticker or compare two or three

Compare

PEN

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for PEN